The role of p53 isoforms’ expression and p53 mutation status in renal cell cancer prognosis
Marijana Knezović Florijan(University Hospital Centre Zagreb), Tvrtko Hudolin(University Hospital Centre Zagreb), Željko Kaštelan(University Hospital Centre Zagreb), Laura Pezzè(University of Trento), Yari Ciribilli(University of Trento), Neda Slade(Ruđer Bošković Institute), Petar Ozretić(Rudjer Boskovic Institute), Maro Bujak(Rudjer Boskovic Institute)
Cited by 22
Related Papers
Fractionation and turnover of stable carbon isotopes in animal tissues: Implications for ?13C analysis of diet
|Oecologia|1983|1.8k
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
|Proceedings of the National Academy of Sciences|2007|598
p63 and p73: Roles in Development and Tumor Formation
|Molecular Cancer Research|2004|492
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
|The Journal of Experimental Medicine|2002|317
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
|Kidney International|2011|213